Myocardial stunning in hypertrophic cardiomyopathy: recovery predicted by single photon emission computed tomographic thallium-201 scintigraphy.
A young woman with hypertrophic cardiomyopathy confirmed by echocardiography and cardiac catheterization presented with chest pain and features of a large left ventricular aneurysm. The initial diagnosis was myocardial ischemia with either an evolving or an ancient myocardial infarction. Subsequently, verapamil therapy was associated with complete resolution of the extensive left ventricular wall motion abnormalities, normalization of left ventricular ejection fraction and a minimal myocardial infarction. Normal thallium uptake on single photon emission computed tomographic scintigraphy early in the hospital course predicted myocardial viability in the region of the aneurysm. Thus, orally administered verapamil may reverse spontaneous extensive myocardial ischemia in hypertrophic cardiomyopathy and possibly limit the extent of myocardial infarction in such circumstances.
Fine
D G
DG
Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic, Rochester, Minnesota 55905.
Clements
I P
IP
Callahan
M J
MJ
D000328:Adult; D002312:Cardiomyopathy, Hypertrophic / Q000150:complications*; D003327:Coronary Disease / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000209:etiology*; D005260:Female; D006321:Heart / Q000000981:diagnostic imaging*; D006801:Humans; D009200:Myocardial Contraction; D013318:Stroke Volume; D013794:Thallium Radioisotopes; D014055:Tomography, Emission-Computed; D014700:Verapamil / Q000627:therapeutic use
D013794:Thallium Radioisotopes; D014700:Verapamil